Metabolic Syndrome in Type 1 Diabetes
Lena M. Thorn(University of Helsinki), Clas-Göran af Björkesten(Helsinki University Hospital), Merlin C. Thomas(Monash University), Johan Wadén(Helsinki University Hospital), Milla Rosengård‐Bärlund, Mats Rönnback(Helsinki University Hospital), Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Markku Saraheimo(Helsinki University Hospital), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Johan Fagerudd(Helsinki University Hospital), Kim Pettersson-Fernholm(Helsinki University Hospital)
Cited by 428
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k